Healogics, Inc. Completes Acquisition of Accelecare Wound Centers, Inc.
March 02 2015 - 9:09PM
Business Wire
Healogics, Inc., the nation’s largest provider of advanced wound
care services announced today that it has completed the acquisition
of Accelecare Wound Centers, Inc., also a leading provider of wound
care services.
“This transaction makes tremendous sense for the employees and
hospital partners of both companies, and most importantly, the
growing population of patients with chronic wounds,” said Jeff
Nelson, president and chief executive officer for Healogics.
“Combining the two premier wound management companies will allow us
to invest in the further development of the advanced wound care
market. Both companies have invested in physician services
businesses in the last few years, creating opportunities for
physicians to engage in wound care full time. There are significant
opportunities to raise market awareness. With the data we collect
on the large number of wounds treated, we determine the most
effective treatment pathways for our patients and share them across
our provider base.”
Michael Lester, chairman and chief executive officer of
Accelecare said, “This combination will leverage Healogics and
Accelecare’s strengths including talented team members, an
extensive network of wound care physicians, advanced training
opportunities and an innovative wound care technology
platform.”
Nelson went on to say, “Healogics and Accelecare share a passion
for patient care and commitment to quality. We believe this
acquisition moves us one step closer to achieving our mission to
reach and heal more patients wherever they may be, by the best
means available.”
About Healogics
Headquartered in Jacksonville, FL., Healogics is the nation’s
largest provider of advanced wound care services. Healogics and its
affiliated companies manage nearly 600 Wound Care Centers® in the
nation and saw more than 234,000 patients in 2014 through a
connected network of partner hospitals and Wound Care Centers,
academic medical centers, and other post-acute sites. Healogics
utilizes an evidence-based systematic approach to chronic wound
healing to treat an underserved and growing patient population. A
fund managed by Clayton, Dubilier & Rice, a private investment
firm, is the majority shareholder of Healogics. For more
information, please visit www.healogics.com.
About Accelecare Wound Centers
Accelecare Would Centers is a comprehensive wound care and
disease management company. Accelecare provides full service wound
management solutions to hospitals and related health care
organizations across the United States. The company offers state of
the art Advanced Wound Centers staffed with trained physicians,
nurses, and specialized technicians providing efficacious and cost
effective wound treatments ensuring positive outcomes. Accelecare’s
mission is centered around partnering with hospitals in order to
provide patient care with the highest level of clinical excellence.
Revelstoke Capital Partners and its institutional co-investors, are
the majority shareholders of Accelecare.
Healogics, Inc.Jessica Taft,
+1-904-446-3461jessica.taft@healogics.com